Methocarbamol NDC 68083-317

NDC codes

FDA NDC Directory

Product NDC (as listed)68083-317Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68083-0317Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68083-317-25	68083031725	25 VIAL in 1 CARTON (68083-317-25) / 10 mL in 1 VIAL (68083-317-01)Marketed from Nov 1, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methocarbamol
Generic name (nonproprietary): methocarbamol
Active ingredients: Methocarbamol — 100 mg/mL
Dosage form: Injection
Route: Intramuscular, Intravenous
Labeler: Gland Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211504
Marketing start: Nov 1, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers: Product ID 68083-317_36c2242f-82d7-4faa-a640-0a6e269038ffSPL ID 36c2242f-82d7-4faa-a640-0a6e269038ffSPL set ID 44c7fe99-8999-4747-9376-f13d3f9e5688RxCUI 238175UNII 125OD7737X
Pharmacologic class: Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N468083031725 followed by a unit qualifier and the quantity

Package 68083-0317-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 18, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE The injectable form of methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211504

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211504
Product	Strength	Form · route	Labeler	Product NDC
Methocarbamol	Methocarbamol 100 mg/mL	InjectionIntramuscular, Intravenous	Dr.Reddys Laboratories Inc.,	43598-839
Methocarbamol	Methocarbamol 100 mg/mL	InjectionIntramuscular, Intravenous, Intravenous	JVET PHARMACEUTICALS LLC	86211-114
Methocarbamol	Methocarbamol 100 mg/mL	Injection, SolutionIntramuscular, Intravenous	Meitheal Pharmaceuticals Inc.	71288-716
Methocarbamol	Methocarbamol 100 mg/mL	Injection, SolutionIntramuscular, Intravenous	Sagent Pharmaceuticals	25021-689